1. Ouédraogo O, Garanet F, Compaoré E, et al. [Prévalence et facteurs associés au retard de croissance chez des écoliers à Dori, Burkina Faso]. Santé Publique 2019; 31: 153–163. doi: 10.3917/spub.191.0153.
2.
Lindsay R, Feldkamp M, Harris D, et al. Utah growth study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 1994; 125: 29–35. doi: 10.1016/S0022-3476(94)70117-2.
3.
Taieb A, Asma BA, Yosra H, et al. Assessing the adrenal axis by the glucagon stimulation test in children with idiopathic growth hormone deficiency. Pediatr Endocrinol Diabetes Metab 2018; 24: 161–166. doi: 10.5114/pedm.2018.83361.
4.
Bozzola M, Meazza C. Growth hormone deficiency: diagnosis and therapy in children. Expert Rev Endocrinol Metab 2010; 5: 273–284. doi: 10.1586/eem.09.69.
5.
Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000; 85: 3990–3993. doi: 10.1210/jcem.85.11.6984.
6.
Tenenbaum-Rakover Y. The need to revise the cut-off level for the diagnosis of GH deficiency in children. Pediatr Endocrinol Rev 2008; 5: 880–888.
7.
Todt H. [Cerebral seizures induced by spontaneous hypoglycemias. Contribution on the differential diagnosis of convulsive diseases in childhood]. Dtsch Gesundheitsw 1972; 27: 2423–2425.
8.
Galloway PJ, McNeill E, Paterson WF, Donaldson MDC. Safety of the insulin tolerance test. Arch Dis Child 2002; 87: 354–356. doi: 10.1136/adc.87.4.354.
9.
Fish HR, Chernow B, O’Brien JT. Endocrine and neurophysiologic responses of the pituitary to insulin-induced hypoglycemia: a review. Metabolism 1986; 35: 763–780. doi: 10.1016/0026-0495(86)90245-3.
10.
Lone SW, Khan YN, Qamar F, et al. Safety of insulin tolerance test for the assessment of growth hormone deficiency in children. J Pak Med Assoc 2011; 61: 153–157.
11.
Simsek Y, Karaca Z, Diri H, et al. Is biochemical hypoglycemia necessary during an insulin tolerance test? Arch Endocrinol Metab 2020; 64: 82–88. doi: 10.20945/2359-3997000000200.
12.
Takahashi K, Nakamura A, Miyoshi H, et al. Factors associated with inadequate hypoglycemia in the insulin tolerance test in Japanese patients with suspected or proven hypopituitarism. Endocr J 2017; 64: 387–392. doi: 10.1507/endocrj.EJ16-0332. Epub 2017 Mar 3.
13.
Yeoh P, Dwyer AA, Anghel E, et al. A comparison of the blood glucose, growth hormone, and cortisol responses to two doses of insulin (0.15 U/kg vs 0.10 U/kg) in the insulin tolerance test: a single-centre audit of 174 cases. Int J Endocrinol 2022; 2022: 7360282. doi: 10.1155/2022/7360282.
14.
Ibrahim NM, Noor N, Nisa M, et al. Peak growth hormone level variability during insulin tolerance test in children with short stature. J Coll Physicians Surg Pak 2021; 31: 1081–1084. doi: 10.29271/jcpsp.2021.09.1081.
15.
Rhee N, Oh KY, Yang EM, Kim CJ. Growth hormone responses to provocative tests in children with short stature. Chonnam Med J 2015; 51: 33–37. doi: 10.4068/cmj.2015.51.1.33.
16.
Holmer H, Link K, Erfurth EM. Risk for severe hypoglycaemia with unawareness in GH-deficient patients during the insulin tolerance test. Clin Endocrinol (Oxf) 2006; 64: 136–140. doi: 10.1111/j.1365-2265.2006.02436.x.
17.
Jabbar J, Ghani F, Siddiqui I, Omair A. Diagnostic efficacy of growth hormone samples in insulin tolerance test: utility of measurement at different time-points and a cost-effective analysis. Scand J Clin Lab Invest 2009; 69: 359–364. doi: 10.1080/00365510802638707.
18.
Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 2010; 33: 1389–1394. doi: 10.2337/dc09-2082.
19.
Grunstein HS, James DE, Storlien LH, et al. Hyperinsulinemia suppresses glucose utilization in specific brain regions: in vivo studies using the euglycemic clamp in the rat. Endocrinology 1985; 116: 604–610. doi: 10.1210/endo-116-2-604.
20.
Gerich JE, Mokan M, Veneman T, et al. Hypoglycemia unawareness. Endocr Rev 1991; 12: 356–371. doi: 10.1210/edrv-12-4-356.
21.
Unger JW, Lange W. Insulin receptors in the pituitary gland: morphological evidence for influence on opioid peptide-synthesizing cells. Cell Tissue Res 1997; 288: 471–483. doi: 10.1007/s004410050833.
22.
Amiel SA, Simonson DC, Tamborlane WV, et al. Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans. Diabetes 1987; 36: 518–522. doi: 10.2337/diab.36.4.518.
23.
Ajala O, Lockett H, Twine G, Flanagan DE. Depth and duration of hypoglycaemia achieved during the insulin tolerance test. Eur J Endocrinol 2012; 167: 59–65. doi: 10.1530/EJE-12-0068.
24.
Borm K, Slawik M, Beuschlein F, et al. Low-dose glucose infusion after achieving critical hypoglycemia during insulin tolerance testing: effects on time of hypoglycemia, neuroendocrine stress response and patient discomfort in a pilot study. Eur J Endocrinol 2005; 153: 521–526. doi: 10.1530/eje.1.01992.
25.
Lee P, Greenfield JR, Ho KKY. Factors determining inadequate hypoglycaemia during insulin tolerance testing after pituitary surgery. Clin Endocrinol (Oxf) 2009; 71: 82–85. doi: 10.1111/j.1365-2265.2008.03466.x.
26.
Zhang Y, Sun S, Jia H, et al. The optimized calculation method for insulin dosage in an insulin tolerance test (ITT): a randomized parallel control study. Front Endocrinol (Lausanne) 2020; 11: 202. doi: 10.3389/fendo.2020.00202.
27.
Korpi-Steiner N, Nerenz RD. Disorders of the anterior and posterior pituitary. In: Burtis CA, Bruns DE, eds. Contemporary practice in clinical chemistry. Boston, MA, USA: Elsevier; 2020. p. 681–701.
28.
Ministero della Giustizia. Nota 39. Gazzetta Ufficiale della Repubblica Italiana 2014; 154: 2–5. Available at: https://www.gazzettaufficiale.it/eli/gu/2014/07/05/154/sg/pdf.
POLSKI
